Rankings
▼
Calendar
PRAX Q4 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$515,000
Gross Profit
-$18M
-3470.5% margin
Operating Income
-$28M
-5399.2% margin
Net Income
-$27M
-5219.0% margin
EPS (Diluted)
$-2.97
QoQ Revenue Growth
+10.0%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$88M
Total Liabilities
$18M
Stockholders' Equity
$70M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$515,000
$0
—
Gross Profit
-$18M
-$28M
+35.5%
Operating Income
-$28M
-$41M
+32.9%
Net Income
-$27M
-$41M
+34.7%
Revenue Segments
License
$400,000
100%
← FY 2023
All Quarters
Q1 2024 →